Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)

This study has been completed.
Sponsor:
Collaborators:
Chulalongkorn University
Kirby Institute
Radboud University
South East Asia Research Collaboration with Hawaii
Information provided by:
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01138267
First received: June 4, 2010
Last updated: February 3, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)